Trial Search Results

Guidelines for Drug Therapy of Hypertension: Closing the Loop

Hypertension is a major risk factor for heart disease and stroke. Evidence-based guidelines support the use of specific drugs for patients with specific comorbidities to maximize the decrease in cardiovascular risk; yet, many physicians do not follow these guidelines in choosing drug therapy.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

US Department of Veterans Affairs

Collaborator: Stanford University

Stanford Investigator(s):


  • Procedure: Computer generated statements about guideline concordance of drug therapy deliver to clinicians




Inclusion Criteria:

Subjects were primary care clinicians, both physicians and nurse practitioners, at a large
VA medical center. Patients were not subjects in this study.

Exclusion Criteria:

Ages Eligible for Study

N/A - N/A

Genders Eligible for Study


Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Not Recruiting